ALNY icon

Alnylam Pharmaceuticals
ALNY

Overview Fund Activity

518 hedge funds and large institutions have $29.1B invested in Alnylam Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 194 increasing their positions, 164 reducing their positions, and 57 closing their positions.

Holders
518
Holders Change
+23
Holders Change %
+4.65%
% of All Funds
7.54%
Holding in Top 10
6
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-25%
% of All Funds
0.09%
New
87
Increased
194
Reduced
164
Closed
57
Calls
$703M
Puts
$600M
Net Calls
+$103M
Net Calls Change
-$53.2M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.96B
2
Capital World Investors
2
Capital World Investors
California
$3.64B
3
OAG
3
Orbis Allan Gray
Bermuda
$175M
4
BlackRock
4
BlackRock
New York
$2.32B
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$3.04B

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$1.51B
2
Baillie Gifford & Co
2
Baillie Gifford & Co
United Kingdom
$1.47B
3
Squarepoint
3
Squarepoint
New York
$24M
4
DTC
4
Deep Track Capital
Connecticut
$122M
5
VPC
5
Vestal Point Capital
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Capital World Investors
1
Capital World Investors
California
$3.64B 14,971,343 +2,182,107 +17%
Vanguard Group
2
Vanguard Group
Pennsylvania
$3.04B 12,507,778 +513,517 +4%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$2.96B 12,164,038 +2,196,042 +22%
BlackRock
4
BlackRock
New York
$2.32B 9,547,663 +522,656 +6%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$1.51B 6,210,479 -998,526 -14%
Baillie Gifford & Co
6
Baillie Gifford & Co
United Kingdom
$1.47B 6,032,656 -590,921 -9%
Capital International Investors
7
Capital International Investors
California
$946M 3,891,059 +239,842 +7%
Dodge & Cox
8
Dodge & Cox
California
$919M 3,780,185 -31,295 -0.8%
State Street
9
State Street
Massachusetts
$859M 3,534,836 +343,463 +11%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$848M 3,488,003 -197,750 -5%
Capital Research Global Investors
11
Capital Research Global Investors
California
$791M 3,255,648 +110,661 +4%
T. Rowe Price Investment Management
12
T. Rowe Price Investment Management
Maryland
$766M 3,153,627 +280,723 +10%
Norges Bank
13
Norges Bank
Norway
$558M 2,296,781 +4,127 +0.2%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$505M 2,080,275 +78,557 +4%
JPMorgan Chase & Co
15
JPMorgan Chase & Co
New York
$431M 1,772,871 +24,682 +1%
American Century Companies
16
American Century Companies
Missouri
$329M 1,354,169 -19,485 -1%
BG
17
Bellevue Group
Switzerland
$224M 919,834 +1,550 +0.2%
UBS AM
18
UBS AM
Illinois
$203M 835,413 +76,763 +10%
Northern Trust
19
Northern Trust
Illinois
$190M 780,835 +41,251 +6%
Legal & General Group
20
Legal & General Group
United Kingdom
$185M 761,919 +11,317 +2%
Pictet Asset Management
21
Pictet Asset Management
Switzerland
$184M 758,528 -202,976 -21%
Amundi
22
Amundi
France
$183M 737,290 -8,774 -1%
Morgan Stanley
23
Morgan Stanley
New York
$180M 741,514 +66,233 +10%
OAG
24
Orbis Allan Gray
Bermuda
$175M 721,053 +721,053 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$164M 673,702 -124,743 -16%
1
2 3 4 5